Final answer:
Pharmacists and healthcare administration are accountable for medication control in healthcare facilities, with regulation by the FDA, which can delay drug availability, affecting patients in need of new treatments.
Step-by-step explanation:
Those responsible for medications in a facility and for establishing a system of control for all drugs dispensed are usually the pharmacists and the healthcare administration. The Food and Drug Administration (FDA) plays a key role in ensuring the safety and efficacy of medications available in the market. However, this regulatory oversight can lead to significant delays in the availability of new drugs, which can be detrimental to patients awaiting novel treatments. On one hand, the public benefits from protection against unsafe drugs, while on the other hand, individuals who might benefit from new therapies are the more anonymous losers in a system with strict medical regulations. These regulations can lead to prolonged wait times for drug approvals, potentially denying patients access to lifesaving treatments. In the context of medication dispensing and control within healthcare facilities, processes such as directly observed therapy (DOT) help ensure compliance but may not be practical or cost-effective for all medications.